These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22466864)

  • 1. Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications.
    Menéndez ST; Villaronga MA; Rodrigo JP; Alvarez-Teijeiro S; García-Carracedo D; Urdinguio RG; Fraga MF; Pardo LA; Viloria CG; Suárez C; García-Pedrero JM
    J Mol Med (Berl); 2012 Oct; 90(10):1173-84. PubMed ID: 22466864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.
    Menéndez ST; Rodrigo JP; Alvarez-Teijeiro S; Villaronga MÁ; Allonca E; Vallina A; Astudillo A; Barros F; Suárez C; García-Pedrero JM
    Mod Pathol; 2012 Aug; 25(8):1069-78. PubMed ID: 22460808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms.
    Menéndez ST; Villaronga MÁ; Rodrigo JP; Álvarez-Teijeiro S; Urdinguio RG; Fraga MF; Suárez C; García-Pedrero JM
    Sci Rep; 2016 Jan; 6():19666. PubMed ID: 26785772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry.
    Hammadi M; Chopin V; Matifat F; Dhennin-Duthille I; Chasseraud M; Sevestre H; Ouadid-Ahidouch H
    J Cell Physiol; 2012 Dec; 227(12):3837-46. PubMed ID: 22495877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of potassium channel ether à go-go in human osteosarcoma.
    Wu J; Wu X; Lian K; Lin B; Guo L; Ding Z
    Neoplasma; 2012; 59(2):207-15. PubMed ID: 22248279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia.
    Agarwal JR; Griesinger F; Stühmer W; Pardo LA
    Mol Cancer; 2010 Jan; 9():18. PubMed ID: 20105281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human ether-à-go-go gene potassium channels are regulated by EGFR tyrosine kinase.
    Wu W; Dong MQ; Wu XG; Sun HY; Tse HF; Lau CP; Li GR
    Biochim Biophys Acta; 2012 Feb; 1823(2):282-9. PubMed ID: 22061963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cis-acting element in the promoter of human ether à go-go 1 potassium channel gene mediates repression by calcitriol in human cervical cancer cells.
    Cázares-Ordoñez V; González-Duarte RJ; Díaz L; Ishizawa M; Uno S; Ortíz V; Ordoñez-Sánchez ML; Makishima M; Larrea F; Avila E
    Biochem Cell Biol; 2015 Feb; 93(1):94-101. PubMed ID: 25495694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BKCa and hEag1 channels regulate cell proliferation and differentiation in human bone marrow-derived mesenchymal stem cells.
    Zhang YY; Yue J; Che H; Sun HY; Tse HF; Li GR
    J Cell Physiol; 2014 Feb; 229(2):202-12. PubMed ID: 23881642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.
    Pier DM; Shehatou GS; Giblett S; Pullar CE; Trezise DJ; Pritchard CA; Challiss RA; Mitcheson JS
    Mol Pharmacol; 2014 Aug; 86(2):211-21. PubMed ID: 24830940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corydaline binds to a druggable pocket of hEAG1 channel and inhibits hepatic carcinoma cell viability.
    Ma B; Shi S; Ren S; Qu C; Zhao Z; An H
    Eur J Pharmacol; 2024 Jan; 962():176240. PubMed ID: 38048981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells: the critical role of hEag1 channels in G1 phase progression.
    Borowiec AS; Hague F; Gouilleux-Gruart V; Lassoued K; Ouadid-Ahidouch H
    Biochim Biophys Acta; 2011 May; 1813(5):723-30. PubMed ID: 21315112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HERG1 potassium channel expression in potentially malignant disorders of the oral mucosa and prognostic relevance in oral squamous cell carcinoma.
    Fernández-Valle Á; Rodrigo JP; Rodríguez-Santamarta T; Villaronga MÁ; Álvarez-Teijeiro S; García-Pedrero JM; Suárez-Fernández L; Lequerica-Fernández P; de Vicente JC
    Head Neck; 2016 Nov; 38(11):1672-1678. PubMed ID: 27131339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of hEAG1 potassium channels by arachidonic acid.
    Gavrilova-Ruch O; Schönherr R; Heinemann SH
    Pflugers Arch; 2007 Mar; 453(6):891-903. PubMed ID: 17120019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target.
    Ma L; Chin YKY; Dekan Z; Herzig V; Chow CY; Heighway J; Lam SW; Guillemin GJ; Alewood PF; King GF
    Biochem Pharmacol; 2018 Dec; 158():60-72. PubMed ID: 30149017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin.
    Schönherr R; Löber K; Heinemann SH
    EMBO J; 2000 Jul; 19(13):3263-71. PubMed ID: 10880439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
    Díaz L; Ceja-Ochoa I; Restrepo-Angulo I; Larrea F; Avila-Chávez E; García-Becerra R; Borja-Cacho E; Barrera D; Ahumada E; Gariglio P; Alvarez-Rios E; Ocadiz-Delgado R; Garcia-Villa E; Hernández-Gallegos E; Camacho-Arroyo I; Morales A; Ordaz-Rosado D; García-Latorre E; Escamilla J; Sánchez-Peña LC; Saqui-Salces M; Gamboa-Dominguez A; Vera E; Uribe-Ramírez M; Murbartián J; Ortiz CS; Rivera-Guevara C; De Vizcaya-Ruiz A; Camacho J
    Cancer Res; 2009 Apr; 69(8):3300-7. PubMed ID: 19351862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.